Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03141853 · ClinicalTrials.gov registry record · NA

Horses and Education as Arthritis Therapy

A NA study of Arthritis, sponsored by University of Missouri, Kansas City.

Completed
Registry status
NA
Development phase
21
Enrollment target
3
Study locations

NCT03141853: Completed NA study of Arthritis, sponsored by University of Missouri, Kansas City.

NCT03141853 is a NA study of Arthritis that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 21 participants, below the 4,510-participant average among 48 other Arthritis trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03141853, a NA study of Arthritis, has completed, sponsored by University of Missouri, Kansas City.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
3
Study locations

Study Summary

A study will be conducted to assess if adults and older adults with arthritis who ride horses are able to move better, have less pain, enjoy nature more and have a better quality of life then people who go to class to learn about exercise. This is needed because adults with arthritis experience joint pain, stiffness, damage to their cartilage, and decreased range of motion in their hips, knees, shoulders, and back. This study will measure effects on patient's joints, pain, quality of life, muscle and cartilage before and after either arthritis exercise education or horse riding. Horses have unique movements that target joints without weight bearing and possibly show improvements without joint damage. Twenty two subjects will be assigned to either the equine-assisted therapy (EAT) group or a group receiving exercise education for 1 hour each week for 6 weeks. Outcomes of pain, joint mobility and quality of life are measured at 0, 3 and 6 weeks. Enjoyment will be determined by a survey. Safety procedures include helmets, side walking attendants for balance, and controlled by a certified riding instructor at a certified riding center. Data will be gathered and reviewed, to assess the effects of EAT on arthritis.

Primary Outcome

Data on attendance will be collected at 0 (screening), 1, 2, 3, 4, 5, and week 6. Tracking of de-identified will be measured. Data will be aggregated according to intervention vs. control group.

Conditions Studied

Interventions

  • OTHER Equine-assisted Therapy
  • OTHER Arthritis Exercise Education

Study Locations (3)

Missouri

  • Kansas City Physician's Partners - Kansas City
  • Saint Luke's College of Health Sciences - Kansas City

Kansas

  • Due West Therapeutic Riding Center - Kansas City

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-05-20
Est. Completion 2017-12-20
Phase NA

What the finished NCT03141853 record still lists

NCT03141853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 4,510-participant average among 48 other Arthritis trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Equine-assisted Therapy is the first listed.

NCT03141853 reports a single indexed study location in Missouri, Kansas.

Frequently Asked Questions

What is clinical trial NCT03141853 about?

NCT03141853 is a clinical study titled "Horses and Education as Arthritis Therapy". A study will be conducted to assess if adults and older adults with arthritis who ride horses are able to move better, have less pain, enjoy nature more and have a better quality of life then people who go to class to learn about exercise. This is needed because adults with arthritis experience join...

What is the current status of trial NCT03141853?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-05-20. Estimated completion is 2017-12-20.

What conditions does trial NCT03141853 study?

This clinical trial studies the following conditions: Arthritis.

What interventions are being tested in trial NCT03141853?

The interventions under investigation include: Equine-assisted Therapy (OTHER), Arthritis Exercise Education (OTHER).

Who is sponsoring clinical trial NCT03141853?

This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03141853 being conducted?

This trial has 3 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03141853's enrollment target sits among peer trials

21 43rd of 48 higher than 6 of 48 other Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03141853, the US trial registry maintained by the National Library of Medicine. NCT03141853 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.